Last update 21 Dec 2024

Lerdelimumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-TGF-beta-2 monoclonal antibody, Anti-transforming-growth-factor-beta-2 monoclonal antibody, Human anti-TGF-beta-2 monoclonal antibody
+ [5]
Target
Mechanism
TGF-β2 inhibitors(Transforming growth factor beta 2 inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-Lerdelimumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CicatrixPhase 3
US
-
CicatrixPhase 3--
CicatrixPhase 3
ZA
-
CicatrixPhase 3--
CataractPhase 2--
CataractPhase 2--
Vitreoretinopathy, ProliferativePhase 2
GB
-
Vitreoretinopathy, ProliferativePhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
56
yfzuwgivsn(enhiwqjpjk) = Events coded to 'Eye Disorders' were the most common, comprising 84% of all events; and of these the most common were in the 'Ocular Infections, Irritations and Inflammations' category with 14% Trabio patients and 25% of the placebo patients reporting one or more events owftnrptvu (qnaiqdqpsr )
Positive
01 May 2004
Placebo
Not Applicable
TGFß2
-
nbfojpnlvi(zrynpskcdt) = mhpuchthqu ahkrzgdacq (xmrztprboa )
Positive
01 May 2003
Placebo (phosphate buffered saline)
avhzoopbrq(otidprdfmp) = zmczjfeidk ulffqudtpv (bxkrkhgrnv )
Not Applicable
Blister
Maintenance
27
mafbaqslez(uvhmkgwpew) = 5-FU caused corneal epitheliopathy (p=0.003) ippxxjsryx (qxkjlvbtpi )
-
01 May 2003
Not Applicable
-
54
cwafudwmuc(cdlltxbcvs) = eynszvygbx bbxexbhxbn (zlphjonfbb )
-
01 Dec 2002
5-fluorouracil (5-FU) (50mg/ml)
cwafudwmuc(cdlltxbcvs) = crwdbyolim bbxexbhxbn (zlphjonfbb )
Not Applicable
-
CAT-152 100µg
hyoutwmakx(cakwcegxnq) = eyrypqrlnz zfbozdjvcq (dwykqreukr )
-
01 Dec 2002
Placebo
hyoutwmakx(cakwcegxnq) = osfveuhbzv zfbozdjvcq (dwykqreukr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free